Metis Global Partners, LLC Danaher Corp Transaction History

Metis Global Partners, LLC

$2.87 Billion
Q2 2024

A detailed history of Metis Global Partners, LLC transactions in Danaher Corp stock. As of the latest transaction made, Metis Global Partners, LLC holds 41,856 shares of DHR stock, worth $11.5 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

41,856

Previous 41,240 1.49%

Holding current value

$11.5 Million

Previous $10.3 Million 1.54%

% of portfolio

0.36%

Previous 0.38%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$235.51 - $267.98 $145,074 - $165,075	616 Added 1.49%	41,856 $10.5 Million
Q1 2024 May 06, 2024	BUY	$224.58 - $256.19 $88,933 - $101,451	396 Added 0.97%	41,240 $10.3 Million
Q4 2023 Feb 06, 2024	BUY	$185.1 - $233.13 $1.02 Million - $1.29 Million	5,512 Added 15.6%	40,844 $9.45 Million
Q3 2023 Nov 07, 2023	BUY	$233.08 - $265.59 $1.04 Million - $1.19 Million	4,481 Added 14.52%	35,332 $8.77 Million
Q2 2023 Aug 07, 2023	BUY	$224.99 - $256.14 $320,385 - $364,743	1,424 Added 4.84%	30,851 $7.4 Million
Q1 2023 May 08, 2023	BUY	$239.75 - $277.0 $1.51 Million - $1.74 Million	6,299 Added 27.24%	29,427 $7.42 Million
Q4 2022 Feb 07, 2023	BUY	$241.42 - $282.29 $2.4 Million - $2.81 Million	9,951 Added 75.52%	23,128 $6.14 Million
Q3 2022 Nov 08, 2022	BUY	$247.06 - $1507.4 $401,472 - $2.45 Million	1,625 Added 14.07%	13,177 $3.4 Million
Q2 2022 Aug 08, 2022	BUY	$237.11 - $299.66 $349,263 - $441,399	1,473 Added 14.61%	11,552 $2.93 Million
Q1 2022 May 03, 2022	BUY	$257.27 - $315.76 $1.15 Million - $1.41 Million	4,452 Added 79.12%	10,079 $2.96 Million
Q4 2021 Feb 11, 2022	BUY	$292.08 - $329.01 $1.64 Million - $1.85 Million	5,627 New	5,627 $1.85 Million

Others Institutions Holding DHR

# of Institutions

2,389

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.1M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $201B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.

Account

Metis Global Partners, LLC Danaher Corp Transaction History